CADD-Solis Ambulatory Infusion Pumps Amendment

This solicitation amendment pertains to CADD-Solis Ambulatory Infusion Pumps, including related accessories such as pole mount adapters, lockable pole mount brackets, and clear lockboxes, as well as medication safety software licenses. The amendment extends the offer due date and updates delivery and inspection/acceptance locations. The requirement includes version upgrade implementation. The items are to be delivered to Fort Bliss, Texas. The solicitation specifies that the products must be FDA approved and not have any unresolved FDA recalls. The infusion pumps should be Patient Controlled Analgesics capable of epidural and intravenous delivery modes, with a linear peristaltic pump mechanism. They must include indicators, alarms, and dose error reduction features, with a weight between 2-3 pounds and a flow range of 0-100 Continuous/0-500 Bolus. The pumps must be compatible with central lines. The seller must be an authorized dealer, distributor, or reseller and provide a warranty in accordance with Original Equipment Manufacturer (OEM) guidance. The award will be made on an all-or-none basis to the responsible contractor whose quote demonstrates acceptable technical capability and fair and reasonable pricing.